Login to Your Account



Celgene Buying Anthrogenesis For $45M, Expanding Portfolio

By Brady Huggett


Friday, November 15, 2002
Celgene Corp. is shelling out $45 million in stock and options to acquire a subsidiary - a placental stem cell recovery company called Anthrogenesis Corp. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription